Cyril Mamotte

4.4k citations

67 papers · 3.4k indexed · 1 hit paper · h-index 26

Molecular Biology top 10%
Pharmacology top 1%
Surgery top 5%
Physiology top 5%
Rheumatology top 2%

Co-authors: Frank M. van Bockxmeer Roger R. Taylor S. Mallal David Nolan Ian James D. Sayer Campbell S. Witt A. Castley
Topics: Lipoproteins and Cardiovascular Health (9 papers)Immune Cell Function and Interaction (7 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers)
Cited by: Virology Pharmacology Rheumatology
Journals: The Lancet Circulation PLoS ONE
Partner nations: Australia Canada United States

In The Last Decade

Cyril Mamotte

67 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

2002 1.0k citations S. Mallal, David Nolan et al. The Lancet profile →

Peers

Countries citing papers authored by Cyril Mamotte

Since Specialization

Citations

This map shows the geographic impact of Cyril Mamotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Mamotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Mamotte more than expected).

Fields of papers citing papers by Cyril Mamotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Mamotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Mamotte. The network helps show where Cyril Mamotte may publish in the future.

Co-authorship network of co-authors of Cyril Mamotte

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Mamotte. A scholar is included among the top collaborators of Cyril Mamotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Mamotte. Cyril Mamotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural products as a source of Coronavirus entry inhibitors 2024 ·Frontiers in Cellular and Infection Microbiology ·(unknown),(unknown),Cyril Mamotte,Pádraig Strappe	5
2	Use of virus-like particles as a native membrane model to study the interaction of insulin with the insulin receptor 2019 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown),Erik Helmerhorst,(unknown),(unknown),Kylie Munyard,Philip Newsholme,Cyril Mamotte	4
3	GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation 2017 ·Scientific Reports ·Rodrigo Carlessi,Younan Chen,Jordan Rowlands,Vínicius Fernandes Cruzat,Kevin N. Keane,(unknown),Cyril Mamotte,Rebecca Stokes,Jenny E. Gunton,Paulo Ivo Homem de Bittencourt,Philip Newsholme	95
4	Nutrient regulation of β-cell function: what do islet cell/animal studies tell us? 2017 ·European Journal of Clinical Nutrition ·Rodrigo Carlessi,Kevin N. Keane,Cyril Mamotte,Philip Newsholme	11
5	Mesothelioma Tumor Cells Modulate Dendritic Cell Lipid Content, Phenotype and Function 2015 ·PLoS ONE ·(unknown),Cyril Mamotte,(unknown),(unknown),Connie Jackaman,Delia J. Nelson	43
6	Primary acute dengue and the deletion in chemokine receptor 5 (CCR5Δ32) 2014 ·Microbes and Infection ·(unknown),(unknown),(unknown),(unknown),David Speers,Cyril Mamotte,David T. Williams	6
7	Conditional testing of multiple variants associated with bone mineral density in the FLNB gene region suggests that they represent a single association signal 2013 ·BMC Genetics ·Benjamin H. Mullin,Cyril Mamotte,Richard L. Prince,Tim D. Spector,Frank Dudbridge,Scott G. Wilson	7
8	A map of the class III region of the sheep major histocompatibilty complex 2008 ·BMC Genomics ·(unknown),Cyril Mamotte,(unknown),(unknown),(unknown)	10
9	HLA‐B5701* typing: evaluation of an allele‐specific polymerase chain reaction melting assay 2007 ·Tissue Antigens ·E. Hammond,Cyril Mamotte,David Nolan,S. Mallal	34
10	LDL-Receptor mRNA Expression in Men Is Downregulated within an Hour of an Acute Fat Load and Is Influenced by Genetic Polymorphism , ,3 2007 ·Journal of Nutrition ·(unknown),Roger R. Taylor,Ian James,Cyril Mamotte	13
11	Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy 2003 ·AIDS ·(unknown),(unknown),A. Castley,D. Sayer,Cyril Mamotte,Mina John,(unknown),S. Mallal	1
12	Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease 2003 ·Atherosclerosis ·(unknown),(unknown),Els Thiry,Fred Van Leuven,Roger R. Taylor,Cyril Mamotte	24
13	Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function 2003 ·Atherosclerosis ·William Bilsborough,Daniel J. Green,Cyril Mamotte,Frank M. van Bockxmeer,G. O’Driscoll,Roger R. Taylor	26
14	Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection 2003 ·Journal of Medical Virology ·Gerry MacQuillan,Cyril Mamotte,W D Reed,Gary P. Jeffrey,Jane E. Allan	56
15	Association between presence of HLA-B5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavirbreakdown → 2002 ·The Lancet* ·S. Mallal,David Nolan,Campbell S. Witt,(unknown),(unknown),Corey Moore,D. Sayer,A. Castley,Cyril Mamotte,Donald M. Maxwell,Ian James,Christiansen Ft	1001
16	Evidence of reduced coronary artery disease risk for apolipoprotein ϵ2/3 heterozygotes 2002 ·European Journal of Internal Medicine ·Cyril Mamotte,Valerie Burke,Roger R. Taylor,Frank M. van Bockxmeer	11
17	Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population 2001 ·European Journal of Cardiovascular Prevention & Rehabilitation ·(unknown),Roger R. Taylor,F. M. van Bockxmeer,Cyril Mamotte	86
18	Butyrylcholinesterase K variant and Alzheimer's disease 1999 ·Journal of Neurology ·Peter K. Panegyres,Cyril Mamotte,Samuel D Vasikaran,Steve D. Wilton,Vicki Fabian,Byron A. Kakulas	24
19	The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle 1998 ·Atherosclerosis ·(unknown),Cyril Mamotte,Frank M. van Bockxmeer,Roger R. Taylor	66
20	Apolipoprotein ε4 homozygosity — a determinant of restenosis after coronary angioplasty 1994 ·Atherosclerosis ·(unknown),Cyril Mamotte,(unknown),Rebekah T. Taylor	29

About Cyril Mamotte

Cyril Mamotte is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Rheumatology, having authored 67 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (9 papers), Immune Cell Function and Interaction (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). The work is most often cited by research in Virology (225 citations), Pharmacology (676 citations) and Rheumatology (504 citations). Cyril Mamotte has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Frank M. van Bockxmeer, Roger R. Taylor, S. Mallal, David Nolan, Ian James, D. Sayer, Campbell S. Witt, A. Castley, Corey Moore and Donald M. Maxwell. Their work appears in journals such as The Lancet, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact